[ad_1]
BEIJING, April 21 (Xinhua) – The five-year survival rate for Chinese bad cancer patients reached 83.2 percent, up 7.3 percent from ten years ago, according to the meeting. Breast Cancer Annual 2019 organized by the Chinese Society of Clinical Oncology (CSCO).
New bad cancer cases account for 16.51% of new cases of malignancy among women in China, making it the most common cancer among women, according to the meeting.
An updated guideline on the diagnosis and treatment of bad cancer was published at the meeting.
"The new directive has incorporated content on independently developed medicines from China and updated content on all bad cancer subtypes of all stages," said CSCO Secretary General Jiang Zefei. Of the reunion.
An intelligent system that helps physicians make clinical decisions was released at the meeting.
According to the meeting, several hospitals have set up a large data platform collecting clinical data on bad cancer, which will help doctors optimize clinical decisions.
Source link
